Suchergebnisse - "Antibodies, Monoclonal, Humanized"

PubPharm (30.523)

51

Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment : Results from the CLEAR study

enthalten in: Journal of the American Academy of Dermatology | 2019

von Thaçi, D. | Puig, L. | Reich, K. | +12

52

Pregnancy Prolongation After Eculizumab Use in Early-Onset Preeclampsia

enthalten in: Obstetrics and gynecology | 2019

von Lu, A. | Lazarus, B. | Rolnik, D. | +1

53

The effectiveness of Reslizumab in severe asthma treatment : a real-world experience

enthalten in: Respiratory research | 2019

von Ibrahim, H. | O'Sullivan, R. | Casey, D. | +4

54

Impact of hypertensive emergency and rare complement variants on the presentation and outcome of atypical hemolytic uremic syndrome

enthalten in: Haematologica | 2019

von El Karoui, K. | Boudhabhay, I. | Petitprez, F. | +9

55

Molecular remissions are observed in chronic adult T-cell leukemia/lymphoma in patients treated with mogamulizumab

enthalten in: Haematologica | 2019

von Cook, L. | Demontis, M. | Sagawe, S. | +10

56

Effect of Early Adverse Events on Survival Outcomes of Patients with Metastatic Colorectal Cancer Treated with Ramucirumab

enthalten in: Targeted oncology | 2019

von Lim, H. | Hopkins, A. | Rowland, A. | +3

57

Immunomodulatory activity of humanized anti-IL-7R monoclonal antibody RN168 in subjects with type 1 diabetes

enthalten in: JCI insight | 2019

von Herold, K. | Bucktrout, S. | Wang, X. | +16

58

Advanced non-small cell lung cancer - Treatment with Pembrolizumab

enthalten in: Revista da Associacao Medica Brasileira (1992) | 2019

von Silvinato, A. | Floriano, I. | Bernardo, W.

59

Strong expression of SLAMF7 in natural killer/T-cell lymphoma and large granular lymphocyte leukemia - a prominent biomarker and potential target for anti-SLAMF7 antibody therapy

enthalten in: Leukemia & lymphoma | 2019

von Elmaagacli, A. | Salwender, H. | Jehn, C. | +6

60

The combination of granulocyte-monocyte apheresis and vedolizumab : A new treatment option for ulcerative colitis?

enthalten in: Journal of clinical apheresis | 2019

von Rodríguez-Lago, I. | Benítez, J. | Sempere, L. | +4